Qurled 400 Tablet

Regulated Product — Business License Required

B2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.

Product photography not yet supplied — this space will show official packaging imagery once provided by the business.

Product Overview

Qurled 400 Tablet contains sofosbuvir, a hepatitis C virus NS5B polymerase inhibitor. Its labelling describes it for the treatment of chronic hepatitis C virus (HCV) infection, used in combination with other antiviral medicines and, in some regimens, in patients who also have cirrhosis or HIV co-infection. The prescriber sets how to take it, when, and for how long.

Active ingredient
Sofosbuvir
Strength
400 mg
Dosage form
Oral film-coated tablet
Therapeutic class
Direct-acting antiviral (HCV NS5B polymerase inhibitor)
Regulatory status
Prescription / regulated — confirmed per enquiry and destination market
Availability
Confirmed per enquiry

Product Information

The following description reflects information associated with sofosbuvir and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.

Described Uses

  • Described for the treatment of chronic hepatitis C virus infection
  • Described as used together with other antiviral medicines, not on its own
  • Described in some regimens for patients who also have cirrhosis or HIV co-infection
Note: SDO Pharma has not independently verified the manufacturer’s efficacy claims for this product and makes no additional medical or clinical claims beyond what is described here. We do not claim FDA, UAE, EU, or other specific regulatory approval for this product unless independently verified. This is a prescription / regulated-status product; patient dispensing is the responsibility of the licensed business customer, not SDO Pharma.

Described Dosage & Administration

  • Taken by mouth as directed by the prescriber, who sets the dose, combination, interval, and duration
  • Tablets should be swallowed whole — not chewed or crushed
  • Doses should not be missed, and the full course should be completed

Described Side Effects

Described side effects of sofosbuvir-based regimens include:

  • Headache
  • Tiredness (fatigue)
  • Nausea
  • Difficulty sleeping

The side-effect profile depends on the medicines combined with it. Any severe, persistent, or unexpected reaction requires prompt medical attention.

Precautions

  • Complete medical details should be shared with the doctor to avoid an inappropriate medicine combination
  • Any allergy to a medicinal component or ingredient should be disclosed before starting treatment
  • Pregnancy should be discussed with the doctor beforehand, and effective contraception is described as advised during treatment
  • The prescriber should be told about all other medicines being taken

This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.

B2B, Import & Export

B2B, Import & Export Enquiries

SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.

We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.

Product Enquiry

Request Product Information

Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.

Frequently Asked Questions

Per its labelling it contains sofosbuvir, an HCV NS5B polymerase inhibitor used with other antiviral medicines to treat chronic hepatitis C virus infection, including some regimens for patients with cirrhosis or HIV co-infection. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.

Its labelling describes it as taken by mouth as directed by the prescriber, who sets the combination, interval, and duration. Tablets are swallowed whole and doses should not be missed.

Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.

Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.

Explore More

Related Product Categories

SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.

View Products & Services